Jeffrey Klausner, MD, MPH
Clinical Professor of Population and Public Health Sciences
From 1998-2009 Dr. Klausner was a Deputy Health Officer, Director of STD Prevention and Control Services at the San Francisco Department of Public Health, member of the UCSF School of Medicine faculty in the Divisions of AIDS and Infectious Diseases and Attending Physician at San Francisco General Hospital. While in San Francisco Dr. Klausner helped identify key factors associated with the increased spread of HIV and STDs and implemented multiple novel public health prevention programs. He helped create the St. James Infirmary, the first occupational health and safety clinic for sex workers and Magnet, a community-based peer-run sexual health clinic for gay men.
From 2009-2011 Dr. Klausner was Branch Chief for HIV and TB at the Centers for Disease Control in Pretoria, South Africa, helping lead the South African PEPFAR program for care and treatment.
After returning from South Africa, from 2011-2021. Klausner was a senior faculty member in the UCLA Division of Infectious Diseases, David Geffen School of Medicine and the Department of Epidemiology at the Fielding School of Public health. At UCLA, Dr. Klausner was the Principal Investigator for multiple NIH-funded networks, projects and studies on sexually transmitted infections in Peru, Botswana, South Africa, Vietnam, Haiti, Pakistan and India antimicrobial resistance and HIV prevention.
Dr. Klausner's research interests are in applied epidemiology and the prevention and control of infectious diseases of public health importance like HIV, STDs, TB, COVID-19 and cryptococcal infections. Dr. Klausner has a particular interest in the use of technology?information, digital, and laboratory?to facilitate access to treatment for disadvantaged populations. Dr. Klausner has been funded by the NIH, CDC, private pharmaceutical and test manufacturers to study the benefits of new ways to find and treat infectious diseases. Dr. Klausner is a frequent advisor to the CDC, NIH and WHO and a popular public speaker. Dr. Klausner is a highly sought after mentor who has trained dozens of fellows, residents and students of medicine and public health.
Resistance-Guided Therapy for Neisseria gonorrhoeae.
Clin Infect Dis. 2022 Jul 12;. doi: 10.1093/cid/ciac371. Epub 2022 Jul 12. PubMed PMID: 35818315;
Association of vision impairment and blindness with socioeconomic status in adults 50 years and older from Alto Amazonas, Peru.
Eye (Lond). 2022 Feb 3;. doi: 10.1038/s41433-021-01870-x. Epub 2022 Feb 3. PubMed PMID: 35115717;
Incidence of Severe Acute Respiratory Syndrome Coronavirus-2 infection among previously infected or vaccinated employees.
Int J Infect Dis. 2022 Feb 10;. doi: 10.1016/j.ijid.2022.02.015. Epub 2022 Feb 10. PubMed PMID: 35151852; PubMed Central PMCID: PMC8828432.
Reliability of Genetic Alterations in Predicting Ceftriaxone Resistance in Neisseria gonorrhoeae Globally.
Microbiol Spectr. 2022 Mar 29;:e0206521. doi: 10.1128/spectrum.02065-21. Epub 2022 Mar 29. PubMed PMID: 35348352;
Substance Use, Violence, and Sexual Risk Among Young Cis-Gender Women Placed at High-Risk for Human Immunodeficiency Virus Infection.
AIDS Behav. 2022 Mar 18;. doi: 10.1007/s10461-022-03631-7. Epub 2022 Mar 18. PubMed PMID: 35303189;